101 related articles for article (PubMed ID: 2444074)
1. Effect of long-term storage on monoamine metabolite levels in human cerebrospinal fluid.
Kobayashi K; Imazu Y; Kawabata M; Shohmori T
Acta Med Okayama; 1987 Aug; 41(4):179-81. PubMed ID: 2444074
[TBL] [Abstract][Full Text] [Related]
2. Stability of monoamine metabolites in human cerebrospinal fluid.
Langlais PJ; Bird ED; McEntee WJ
Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677
[TBL] [Abstract][Full Text] [Related]
3. In-use stability of monoamine metabolites in human cerebrospinal fluid.
Strawn JR; Ekhator NN; Geracioti TD
J Chromatogr B Biomed Sci Appl; 2001 Sep; 760(2):301-6. PubMed ID: 11530989
[TBL] [Abstract][Full Text] [Related]
4. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
[TBL] [Abstract][Full Text] [Related]
5. 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard.
Javors MA; Bowden CL; Maas JW
J Chromatogr; 1984 Dec; 336(2):259-69. PubMed ID: 6085084
[TBL] [Abstract][Full Text] [Related]
6. CSF amine metabolites in depression.
Reddy PL; Khanna S; Subhash MN; Channabasavanna SM; Rao BS
Biol Psychiatry; 1992 Jan; 31(2):112-8. PubMed ID: 1371076
[TBL] [Abstract][Full Text] [Related]
7. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
[TBL] [Abstract][Full Text] [Related]
8. The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients.
Scheepers FE; Gispen-de Wied CC; Westenberg HG; Kahn RS
Neuropsychopharmacology; 2001 Oct; 25(4):468-75. PubMed ID: 11557160
[TBL] [Abstract][Full Text] [Related]
9. Individual differences in basal cisternal cerebrospinal fluid 5-HIAA and HVA in monkeys. The effects of gender, age, physical characteristics, and matrilineal influences.
Raleigh MJ; Brammer GL; McGuire MT; Pollack DB; Yuwiler A
Neuropsychopharmacology; 1992 Dec; 7(4):295-304. PubMed ID: 1282317
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cerebrospinal fluid monoamine metabolite levels in dominant-aggressive and non-aggressive dogs.
Reisner IR; Mann JJ; Stanley M; Huang YY; Houpt KA
Brain Res; 1996 Apr; 714(1-2):57-64. PubMed ID: 8861609
[TBL] [Abstract][Full Text] [Related]
11. Homovanillic acid and 5-hydroxyindoleacetic acid in the ventricular CSF of comatose patients with obstructive hydrocephalus.
Inagawa T; Ishikawa S; Uozumi T
J Neurosurg; 1980 May; 52(5):635-41. PubMed ID: 6154788
[TBL] [Abstract][Full Text] [Related]
12. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
Yoshino K
No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
[TBL] [Abstract][Full Text] [Related]
13. Neuroamine related compounds in the CSF of hydrocephalic rabbits.
Olmstead CE; Lazareff JA; Orlino EN; Fluharty AL; Faull KF; Peacock WJ; Wehby-Grant MC; Gayek RJ; Fisher RS
Neuroreport; 1995 Sep; 6(13):1769-72. PubMed ID: 8541478
[TBL] [Abstract][Full Text] [Related]
14. Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid of chronic therapy-resistant schizophrenics before and after hemodialysis therapy.
Magnusson O; Fowler CJ; Ross SB; Schulman A; Wetterberg L
Artif Organs; 1983 Aug; 7(3):344-8. PubMed ID: 6194776
[TBL] [Abstract][Full Text] [Related]
15. Effects of rat ovariectomy on CSF monoamine metabolite levels and elimination.
Duval C; Mignot E
J Neurochem; 1985 Apr; 44(4):1312-4. PubMed ID: 2579209
[TBL] [Abstract][Full Text] [Related]
16. 5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of children with febrile convulsions.
Giroud M; Dumas R; Dauvergne M; D'Athis P; Rochette L; Beley A; Bralet J
Epilepsia; 1990; 31(2):178-81. PubMed ID: 1690640
[TBL] [Abstract][Full Text] [Related]
17. Concentration gradients for HVA, 5-HIAA, ascorbic acid, and uric acid in cerebrospinal fluid.
Degrell I; Nagy E
Biol Psychiatry; 1990 Apr; 27(8):891-6. PubMed ID: 1691925
[TBL] [Abstract][Full Text] [Related]
18. Characterization of cerebrospinal fluid monoamine metabolites in peripubertal chimpanzees (Pan troglodytes).
Fontenot MB; Musso MW; Watson SL; Anderson GM
J Med Primatol; 2010 Feb; 39(1):24-31. PubMed ID: 19843204
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous measurement of monoamine metabolites and 5-methyltetrahydrofolate in the cerebrospinal fluid of children.
Akiyama T; Hayashi Y; Hanaoka Y; Shibata T; Akiyama M; Nakamura K; Tsuyusaki Y; Kubota M; Yoshinaga H; Kobayashi K
Clin Chim Acta; 2017 Feb; 465():5-10. PubMed ID: 27940130
[TBL] [Abstract][Full Text] [Related]
20. Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.
Nikisch G; Baumann P; Wiedemann G; Kiessling B; Weisser H; Hertel A; Yoshitake T; Kehr J; Mathé AA
J Clin Psychopharmacol; 2010 Oct; 30(5):496-503. PubMed ID: 20814316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
